DE69032324D1 - Zusammensetzung und testverfahren eines elementes als antwort auf ein hormon - Google Patents

Zusammensetzung und testverfahren eines elementes als antwort auf ein hormon

Info

Publication number
DE69032324D1
DE69032324D1 DE69032324T DE69032324T DE69032324D1 DE 69032324 D1 DE69032324 D1 DE 69032324D1 DE 69032324 T DE69032324 T DE 69032324T DE 69032324 T DE69032324 T DE 69032324T DE 69032324 D1 DE69032324 D1 DE 69032324D1
Authority
DE
Germany
Prior art keywords
target gene
hormone
gene specificity
receptor
answer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69032324T
Other languages
English (en)
Other versions
DE69032324T2 (de
Inventor
Ronal Evans
Kazuhiko Omesono
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Salk Institute for Biological Studies
Original Assignee
Salk Institute for Biological Studies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Institute for Biological Studies filed Critical Salk Institute for Biological Studies
Application granted granted Critical
Publication of DE69032324D1 publication Critical patent/DE69032324D1/de
Publication of DE69032324T2 publication Critical patent/DE69032324T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DE69032324T 1989-03-17 1990-03-16 Zusammensetzung und testverfahren eines elementes als antwort auf ein hormon Expired - Fee Related DE69032324T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32524089A 1989-03-17 1989-03-17
PCT/US1990/001428 WO1990011273A1 (en) 1989-03-17 1990-03-16 Hormone response element compositions and assay

Publications (2)

Publication Number Publication Date
DE69032324D1 true DE69032324D1 (de) 1998-06-25
DE69032324T2 DE69032324T2 (de) 1998-10-08

Family

ID=23267026

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69032324T Expired - Fee Related DE69032324T2 (de) 1989-03-17 1990-03-16 Zusammensetzung und testverfahren eines elementes als antwort auf ein hormon

Country Status (8)

Country Link
US (1) US5597693A (de)
EP (1) EP0463081B1 (de)
JP (1) JPH04505012A (de)
AT (1) ATE166360T1 (de)
AU (1) AU655912B2 (de)
CA (1) CA2047752C (de)
DE (1) DE69032324T2 (de)
WO (1) WO1990011273A1 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU665039B2 (en) * 1987-12-02 1995-12-14 Salk Institute For Biological Studies, The Chimeric receptors and methods for identification
US5756448A (en) * 1992-02-26 1998-05-26 The General Hospital Corporation Constitute activator of retinoid (CAR) receptor polypeptides
US6989242B1 (en) 1992-02-26 2006-01-24 The General Hospital Coporation Car receptors and related molecules and methods
EP0577932A3 (de) * 1992-05-08 1995-04-19 American Cyanamid Co Entwicklung von einem "Screening" für den Nachweis von androgenen Rezeptorenagonisten und Antagonisten.
US20050084885A1 (en) * 1994-01-18 2005-04-21 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
US6140466A (en) * 1994-01-18 2000-10-31 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
US6242568B1 (en) * 1994-01-18 2001-06-05 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
JP4118327B2 (ja) 1994-08-20 2008-07-16 ゲンダック・リミテッド Ｄｎａ認識のための結合タンパク質におけるまたはそれに関連する改良
US6306649B1 (en) * 1995-06-27 2001-10-23 Ariad Gene Therapeutics, Inc. Heterologous transcription factors
KR100263137B1 (ko) * 1995-09-08 2000-08-01 오테스코그 페르 오판 수용체
EA003423B1 (ru) 1995-10-10 2003-04-24 Новартис Аг Штамм трансгенных растительных клеток и трансгенное растение, содержащие кассету экспрессии полипептида-мишени usp рецептора, способы получения их потомства, способы регулирования экспрессии полипептида-мишени в указанном растении с помощью ювенильного гормона или его агонистов, способы выявления и получения лиганда для полипептида usp рецептора и соответствующий лиганд
US5728534A (en) * 1996-07-19 1998-03-17 New England Medical Center Hospitals, Inc. Methods for identifying cardiovascular therapeutic agents
US6692928B1 (en) 1996-07-19 2004-02-17 New England Medical Center Hospitals, Inc. Methods for identifying cardiovascular agents
GB9710809D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
US5972639A (en) * 1997-07-24 1999-10-26 Irori Fluorescence-based assays for measuring cell proliferation
US6479653B1 (en) * 1997-08-26 2002-11-12 Ariad Gene Therapeutics, Inc. Compositions and method for regulation of transcription
GB9718455D0 (en) * 1997-09-02 1997-11-05 Mcgregor Duncan P Chimeric binding peptide library screening method
US6222015B1 (en) 1997-09-08 2001-04-24 Merck & Co., Inc. Estrogen receptor
US6410248B1 (en) 1998-01-30 2002-06-25 Massachusetts Institute Of Technology General strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites
WO1999045132A1 (en) * 1998-03-02 1999-09-10 Massachusetts Institute Of Technology Poly zinc finger proteins with improved linkers
ATE336578T1 (de) 1998-03-17 2006-09-15 Gendaq Ltd Nukleinsäurebindungsproteine
CA2336207C (en) 1998-09-10 2004-03-23 Pioneer Hi-Bred International, Inc. Ecdysone receptors and methods for their use
US6140081A (en) * 1998-10-16 2000-10-31 The Scripps Research Institute Zinc finger binding domains for GNN
DE19855013C2 (de) * 1998-11-20 2001-09-13 Schering Ag Androgen- und Progesteron-Rezeptor bindendes Hormon Response Element
US8713641B1 (en) 1998-12-08 2014-04-29 Nomadix, Inc. Systems and methods for authorizing, authenticating and accounting users having transparent computer access to a network using a gateway device
US8266266B2 (en) * 1998-12-08 2012-09-11 Nomadix, Inc. Systems and methods for providing dynamic network authorization, authentication and accounting
US7013219B2 (en) * 1999-01-12 2006-03-14 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US7070934B2 (en) 1999-01-12 2006-07-04 Sangamo Biosciences, Inc. Ligand-controlled regulation of endogenous gene expression
US6453242B1 (en) * 1999-01-12 2002-09-17 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
US6599692B1 (en) * 1999-09-14 2003-07-29 Sangamo Bioscience, Inc. Functional genomics using zinc finger proteins
US6503717B2 (en) * 1999-12-06 2003-01-07 Sangamo Biosciences, Inc. Methods of using randomized libraries of zinc finger proteins for the identification of gene function
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
DE19907099A1 (de) * 1999-02-19 2000-09-07 Theragene Biomedical Lab Gmbh Hormon-Hormonrezeptorkomplexe und Nukleinsäurekonstrukte und ihre Verwendung in der Gentherapie
US6794136B1 (en) 2000-11-20 2004-09-21 Sangamo Biosciences, Inc. Iterative optimization in the design of binding proteins
US20030104526A1 (en) * 1999-03-24 2003-06-05 Qiang Liu Position dependent recognition of GNN nucleotide triplets by zinc fingers
US7030215B2 (en) * 1999-03-24 2006-04-18 Sangamo Biosciences, Inc. Position dependent recognition of GNN nucleotide triplets by zinc fingers
US20020132223A1 (en) * 1999-03-26 2002-09-19 City Of Hope Methods for modulating activity of the FXR nuclear receptor
US6586189B2 (en) 1999-06-18 2003-07-01 City Of Hope Screening method for PPAR-γ ligands
US6548739B2 (en) * 1999-06-18 2003-04-15 City Of Hope Method for activating peroxisome proliferator activated receptor-γ
DE60126913T2 (de) * 2000-01-24 2007-06-28 Gendaq Ltd. Nucleinsäure bindende polypeptide gekennzeichnet durch flexible linker verbundene nucleinsäuredomäne
AU2001252944A1 (en) * 2000-03-24 2001-10-08 City Of Hope Methods of modulating drug clearance mechanisms by altering SXR activity
EP1356066A2 (de) 2000-10-24 2003-10-29 Syngenta Participations AG Kontrolle der pflanzengenexpression
US7067317B2 (en) * 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
AU2884102A (en) * 2000-12-07 2002-06-18 Sangamo Biosciences Inc Regulation of angiogenesis with zinc finger proteins
US7273923B2 (en) 2001-01-22 2007-09-25 Sangamo Biosciences, Inc. Zinc finger proteins for DNA binding and gene regulation in plants
US7067617B2 (en) * 2001-02-21 2006-06-27 The Scripps Research Institute Zinc finger binding domains for nucleotide sequence ANN
EP1288303A1 (de) * 2001-08-23 2003-03-05 Aventis Pharma S.A. Induzierbare Expressionssysteme unter Verwendung von PPAR Transkriptionsaktivatoren
AU2002333682A1 (en) * 2001-08-02 2003-02-17 Gencell S.A. Inducible expression systems employing ppar transcriptional activators
US7262054B2 (en) * 2002-01-22 2007-08-28 Sangamo Biosciences, Inc. Zinc finger proteins for DNA binding and gene regulation in plants
US7361635B2 (en) * 2002-08-29 2008-04-22 Sangamo Biosciences, Inc. Simultaneous modulation of multiple genes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171671A (en) * 1987-12-02 1992-12-15 The Salk Institute For Biological Studies Retinoic acid receptor composition
US4981784A (en) * 1987-12-02 1991-01-01 The Salk Institute For Biological Studies Retinoic acid receptor method
US5274077A (en) * 1987-12-02 1993-12-28 The Salk Institute For Biological Studies Retinoic acid receptor composition

Also Published As

Publication number Publication date
US5597693A (en) 1997-01-28
EP0463081A4 (en) 1992-08-12
AU655912B2 (en) 1995-01-19
EP0463081A1 (de) 1992-01-02
CA2047752C (en) 2001-07-10
ATE166360T1 (de) 1998-06-15
JPH04505012A (ja) 1992-09-03
DE69032324T2 (de) 1998-10-08
AU5342390A (en) 1990-10-22
WO1990011273A1 (en) 1990-10-04
CA2047752A1 (en) 1990-09-18
EP0463081B1 (de) 1998-05-20

Similar Documents

Publication Publication Date Title
DE69032324D1 (de) Zusammensetzung und testverfahren eines elementes als antwort auf ein hormon
Johnson et al. DNA binding and transcriptional regulatory activity of mammalian achaete-scute homologous (MASH) proteins revealed by interaction with a muscle-specific enhancer.
Joshi et al. Endothelial cells adhere to the RGD domain and the fibrinogen-like terminal knob of tenascin
Massague et al. Cellular receptors for type beta transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines.
DE69637136T2 (de) Screening von kombinatorischen Peptidbibliotheken zur Selektion von Peptidliganden zur Verwendung in der Affinitätsreinigung von Zielproteinen
Madan et al. Bidirectional transport of glucocorticoid receptors across the nuclear envelope.
Yamashita et al. Transcription factor TFIIB sites important for interaction with promoter-bound TFIID
DE3751432D1 (de) Rezeptoren für Immunkomplexe, Verfahren zur ihrer Herstellung und Verfahren zur Prüfung diese benutzend.
Greene et al. Immunochemical evaluation of estrogen receptor and progesterone receptor in breast cancer
Almenoff et al. Ligand‐based histochemical localization and capture of cells expressing heat‐stable enterotoxin receptors
DE69403484D1 (de) Prüfungskit
Liu et al. The dominant negative effect of thyroid hormone receptor splicing variant alpha 2 does not require binding to a thyroid response element.
Kakinuma et al. The human thyrotropin (TSH) receptor in a TSH binding inhibition assay for TSH receptor autoantibodies
Lavoie et al. Developmental dependence on NurRE and EboxNeuro for expression of pituitary proopiomelanocortin
Burnett et al. Immunohistochemistry for light microscopy in safety evaluation of therapeutic agents: an overview
Whitlock Jr The control of cytochrome P-450 gene expression by dioxin
ATE198512T1 (de) Transfizierte zelllinien die autoantigene exprimieren und ihre verwendung in immunotests zur erkennung von autoimmunkrankheiten
Bustin et al. Immunological probes for chromatin structure
Casey et al. Peptide mimics selected from immune sera using phage display technology can replace native antigens in the diagnosis of Epstein–Barr virus infection
US6555326B1 (en) Nuclear hormone receptor fluorescence polarization assay
Autschbach et al. Expression of chemokine receptors in normal and inflamed human intestine, tonsil, and liver—an immunohistochemical analysis with new monoclonal antibodies from the 8th international workshop and conference on human leucocyte differentiation antigens
Forejt et al. Gene expression of differentiated parent in teratocarcinoma cell hybrids. Repression or reprogramming?
Luisi et al. Dymer, dymer binding tight.
ATE70311T1 (de) Monoklonale antikoerper gegen menschliche igerezeptoren auf lymphocyten, diese antikoerper produzierende hybridomas und reaktionsansaetze zum gebrauch dieser antikoerper.
Moynagh et al. The Peripheral‐Type Benzodiazepine Receptor Is Present in Astrocytes but Is Not a Primary Site of Action for Convulsants/Anticonvulsants

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee